Mauricio Magalhaes Costa

Mauricio Magalhaes Costa

Auto-generated profile, based on publicly available information

Mauricio Magalhaes Costa

National Academy of Medicine, Rio de Janeiro, Brazil

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 October 2006 in Breast Cancer Research and Treatment
Verified
Journal Article
Closed access
PDF file
MGMagda C. B. Gomes
Magda C. B. Gomes
MCMauricio M. Costa
Mauricio M. Costa
RBRadovan Borojevic
Radovan Borojevic
AMAlvaro Monteiro
Alvaro Monteiro
RVRoberto Vieira
Roberto Vieira
Steven NarodSteven Narod
Steven Narod

1 April 2008 in Cancer Research
Verified
Journal Article
Closed access
PDF file
SZShiyu Zhang
Shiyu Zhang
CPCatherine M. Phelan
Catherine M. Phelan
PZPhil Zhang
Phil Zhang
FRFrancois Rousseau
Francois Rousseau
PGParviz Ghadirian
Parviz Ghadirian
SNSteven A. Narod
Steven A. Narod
A founder allele in the CHEK2 gene (1100delC) has been associated with an elevated risk of breast cancer. This allele is responsible for the majority of CHEK2-associated breast cancers in women from northern European countries; however, within Europe, it seems to be rare in countries that are close to the Mediterranean. The frequency of the 1100delC allele has not been measured in non-White populations. We measured the frequency of the CHEK2 founder allele in 3,882 breast cancer patients and 8,609 controls from various countries. The allele was not seen among Asian patients (from Pakistan or the Philippines) and was present in 1 of 155 cases from Brazil. Among White women, the allele was present in 1.5% of 825 familial cases of breast cancer and in 0.7% of 1,106 patients with nonfamilial breast cancer. The allele was equally frequent in Jewish and non-Jewish patients. We estimate that the CHEK2 1100delC allele is associated with an odds ratio of 2.6 for breast cancer, which corresponds to a lifetime risk of ∼24% in Ontario. [Cancer Res 2008;68(7):2154–7]

1 August 2011 in Molecular Genetics and Metabolism
Verified
Journal Article
Closed access
RCRaquel Guimarães Coelho
Raquel Guimarães Coelho
ICIsadora de Castro Calaça
Isadora de Castro Calaça
DCDeborah de Moura Celestrini
Deborah de Moura Celestrini
ACAna Helena Correia
Ana Helena Correia
MCMauricio Augusto Silva Magalhães Costa
Mauricio Augusto Silva Magalhães Costa
Mauro Sola-PennaMauro Sola-Penna
Mauro Sola-Penna

22 July 2010 in Breast Cancer Research and Treatment
Verified
Journal Article
Closed access
PDF file
APAna Peixoto
Ana Peixoto
CSCatarina Gomes Rodrigues Santos
Catarina Gomes Rodrigues Santos
MPManuela Pinheiro
Manuela Pinheiro
PPPedro Pinto
Pedro Pinto
MSMaria José Soares
Maria José Soares
MTManuel R. Teixeira
Manuel R. Teixeira

7 August 2015 in Oncotarget
Verified
Journal Article
Open access
PDF file
RCRaquel G. Coelho
Raquel G. Coelho
ICIsadora C. Calaça
Isadora C. Calaça
DCDeborah M. Celestrini
Deborah M. Celestrini
ACAna Helena P. Correia-Carneiro
Ana Helena P. Correia-Carneiro
MCMauricio M. Costa
Mauricio M. Costa
Mauro Sola-PennaMauro Sola-Penna
Mauro Sola-Penna
Hexokinase and phosphofructokinase activity and intracellular distribution correlate with aggressiveness and invasiveness of human breast carcinoma

28 August 2009 in Familial Cancer
Verified
Journal Article
Closed access
PDF file
OGOphira Michal Ginsburg
Ophira Michal Ginsburg
MAMohammad R. Akbari
Mohammad R. Akbari
ZAZeba Aziz
Zeba Aziz
RYRobert Young
Robert Young
HLHenry Lynch
Henry Lynch
Steven NarodSteven Narod
Steven Narod